Role of (pro)renin receptor in cyclosporin A-induced nephropathy.

Role of (pro)renin receptor in cyclosporin A-induced nephropathy.
复制标题

肾素(原)受体在环孢菌素 A 诱导的肾病中的作用。

DOI:
10.1152/ajprenal.00332.2021
复制
发表时间:
2022
期刊:
American journal of physiology. Renal physiology
影响因子:
--
通讯作者:
Yang,Tianxin
Yang,Tianxin
中科院分区:
--
文献类型:
--
作者:
Hu,Jiajia;Tan,Yandan;Chen,Yanting;Mo,Shiqi;Hekking,Brittin;Su,Jiahui;Pu,Min;Lu,Aihua;Du,Yanhua;Symons,JDavid;Yang,Tianxin

文献摘要

相似文献

钙调磷酸酶抑制剂如环孢菌素A(CsA)已被广泛用于提高实体器官移植后的移植物存活率。然而,CsA的临床应用往往受到其肾毒性的限制。本研究验证了一个假设,即(原)肾素受体(PRR)的激活有助于通过激活肾素-血管紧张素系统(RAS)的CsA诱导的肾病。低盐饮食联合CsA诱导雄性Sprague-Dawley大鼠肾损伤,表现为血浆肌酐和血尿素氮水平升高,肌酐清除率降低,诱导肾脏炎症、细胞凋亡和间质纤维化,尿N-乙酰-β-d-氨基葡萄糖苷酶活性和尿肾损伤分子-1含量升高。在用PRR诱饵抑制剂PRO 20治疗2周后,肾损伤的每个指数都减弱。尽管CsA治疗的肾损伤大鼠显示肾可溶性PRR丰度、血浆sPRR、肾素活性、血管紧张素II和尿总原肾素/肾素含量升高,但PRO 20减弱了RAS激活。暴露于CsA诱导的人肾近端肾小管HK-2细胞的纤连蛋白表达和sPRR的产生,但纤维化反应减弱PRO20和siRNA介导的PRR敲低。这些发现支持了PRR的激活通过激活大鼠RAS而促进CsA诱导的肾病的假设。重要的是,我们提供了强有力的证据的概念,针对PRR提供了一种新的治疗策略,以限制免疫抑制药物的肾毒性作用。新&值得注意的是,本研究报告,第一次,激活的(原)肾素受体驱动的肾素-血管紧张素系统诱导肾损伤环孢素A管理。更重要的是,我们的研究已经确定,与PRO 20的拮抗作用提供了一种新的干预环孢菌素A副作用的管理。
Calcineurin inhibitors such as cyclosporin A (CsA) have been widely used to improve graft survival following solid-organ transplantation. However, the clinical use of CsA is often limited by its nephrotoxicity. The present study tested the hypothesis that activation of the (pro)renin receptor (PRR) contributes to CsA-induced nephropathy by activating the renin-angiotensin system (RAS). Renal injury in male Sprague-Dawley rats was induced by a low-salt diet combined with CsA as evidenced by elevated plasma creatinine and blood urea nitrogen levels, decreased creatinine clearance and induced renal inflammation, apoptosis and interstitial fibrosis, and elevated urinaryN-acetyl-β-d-glucosaminidase activity and urinary kidney injury molecule-1 content. Each index of renal injury was attenuated following 2 wk of treatment with the PRR decoy inhibitor PRO20. Although CsA-treated rats with kidney injury displayed increased renal soluble (s)PRR abundance, plasma sPRR, renin activity, angiotensin II, and heightened urinary total prorenin/renin content, RAS activation was attenuated by PRO20. Exposure of cultured human renal proximal tubular HK-2 cells to CsA induced expression of fibronectin and sPRR production, but the fibrotic response was attenuated by PRO20 and siRNA-mediated PRR knockdown. These findings support the hypothesis that activation of PRR contributes to CsA-induced nephropathy by activating the RAS in rats. Of importance, we provide strong proof of concept that targeting PRR offers a novel therapeutic strategy to limit nephrotoxic effects of immunosuppressant drugs.NEW & NOTEWORTHYThe present study reports, for the first time, that activation of the (pro)renin receptor drives the renin-angiotensin system to induce renal injury during cyclosporin A administration. More importantly, our study has identified that antagonism with PRO20 offers a novel intervention in the management of side effects of cyclosporin A.